SCHEMBL5267634

SCHEMBL5267634

OCCc1nn(Cc2ccc(Cl)cc2F)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
RORC P51449 1/20 0.38
F2RL3 Q96RI0 6/20 0.37
GRM2 Q14416 1/20 0.36
AKR1B1 P15121 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
ALOX5AP P20292 2/20 0.35
PPARG P37231 3/20 0.35
PPARA Q07869 2/20 0.35
CYP2C9 P11712 2/20 0.35
EGFR P00533 1/20 0.35
CHRM4 P08173 1/20 0.35
ADRB1 P08588 1/20 0.35
ADRA2A P08913 1/20 0.35
ALOX5 P09917 1/20 0.35
ADRB3 P13945 1/20 0.35
DRD2 P14416 1/20 0.35
ADRA2B P18089 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272346 0.94 NR1H2 (0.39) NR1H2NR1H3RORCF2RL3GRM2
SCHEMBL5373644 0.93 NR1H2 (0.38) NR1H2NR1H3RORCF2RL3GRM2
SCHEMBL5383568 0.92 NR1H2 (0.38) NR1H2NR1H3RORCF2RL3GRM2
SCHEMBL5316306 0.92 F2RL3 (0.42) NR1H2NR1H3RORCF2RL3GRM2
SCHEMBL5323336 0.91 TRPV1 (0.42) F2RL3TRPV1PPARGCYP2C9CYP2D6
SCHEMBL5323273 0.90 F2RL3 (0.46) RORCF2RL3AKR1B1ALOX5APCYP2C9
SCHEMBL5318343 0.89 PPARG (0.38) F2RL3TRPV1PPARGPPARACYP2C9
SCHEMBL5316549 0.89 SLC22A12 (0.42) RORCAKR1B1ALOX5APPPARGPPARA
SCHEMBL5323485 0.88 FFAR4 (0.42) RORCAKR1B1PPARGPPARACYP2C9
SCHEMBL5319989 0.86 AKR1B1 (0.52) RORCAKR1B1CYP2C9PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed